相关实验视频
Updated: Sep 10, 2025

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
与IgG4相关的疾病复发的危险因素:系统性审查和元分析
Fan Yang1, Tianqi Wang1, Yanying Liu2
1Department of Rheumatology, Beijing Friendship Hospital, Capital Medical University, No.95 Yong'an Road, Xicheng District, Beijing, China.
患有IgG4相关疾病 (IgG4-RD) 的患者如果过敏,多器官参与或补体水平低,复发率更高. 与皮质类固醇和免疫抑制剂的联合治疗可以减少IgG4-RD复发.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 内部医学 内部医学
背景情况:
- 免疫球蛋白G4相关性疾病 (IgG4-RD) 是一种慢性疾病,在长期管理期间,其复发率很高.
- 确定IgG4-RD复发的危险因素对于优化患者治疗策略至关重要.
研究的目的:
- 系统地审查与IgG4相关疾病复发相关的潜在风险因素.
- 从观察性研究中整合复发率,以提供IgG4-RD.的综合估计.
主要方法:
- 系统审查和对2025年1月28日之前发表的相关文章进行元分析.
- 数据来源于PubMed,EMBASE和Web of Science数据库中的数据.
- 计算了 95% 置信区间 (CI) 的聚合概率比率 (OR) 和危险比率 (HR).
主要成果:
- 分析了24项涉及3797名患者的研究.
- 确定的重大复发风险因素包括过敏史 (OR: 2.97),多器官参与 (HR: 1.60) 和补体水平下降 (HR: 2.27).
- 与皮质类固醇和免疫抑制剂的联合治疗显著降低了复发率 (HR:0.25). 在12个月,24个月和36个月的复发率分别为17%,26%和33%.
结论:
- 过敏史,多器官参与和补体水平下降是IgG4-RD复发的确诊危险因素.
- 联合皮质类固醇和免疫抑制剂疗法在降低IgG4-RD复发率方面表现出有效性.
- 了解这些因素有助于对IgG4-RD患者进行个性化风险评估和治疗计划.
更多相关视频
10:27Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
相关概念视频
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...